Bursitis

10 povidone iodine solution in this article refers to 10% povidone iodine solution, which means that this solution contains 10% povidone iodine (equivalent to 1% titratable iodine) and is a disinfectant. What are the main uses of 10 povidone iodine solution?   About povidone iodine Povidone iodine is a loose complex formed by combining elemental iodine and a polymer carrier, with povidone acting as a carrier and solubilizer. It is a yellow-brown to brown-red amorphous powder at room temperature. It has a slight odor and is easily soluble in water or ethanol. The aqueous solution is acidic and insoluble in ether, chloroform, acetone, ethane and carbon tetrachloride. Povidone iodine solution does not have the disadvantages of iodine tincture, is lightly colored, easy to wash off, has little irritation to the mucous membrane, does not require ethanol deiodination, has no corrosive effect, and has low toxicity.   10 povidone iodine solution can effectively kill Newcastle disease, bursal disease, avian influenza, mycoplasma, Escherichia coli, salmonella, influenza, blue ear disease, etc. It can also kill parasite eggs of livestock and poultry, and inhibit the breeding of insects such as mosquitoes and flies. It can also be used in fruit trees, crops, fish and shrimp farming.   10 povidone iodine solution is an external disinfectant used for cuts, abrasions, burns and minor skin wounds. Its mechanism of action is that after this product contacts the wound or the affected area, it can depolymerize and release the iodine contained to exert a bactericidal effect. It has the characteristics of low irritation to tissues and is suitable for skin and mucous membrane infections. It is usually used for purulent dermatitis, fungal skin infection, and small-area mild burns and scalds. It is also used to disinfect small-area skin and mucosal wounds. It is also a medical disinfectant used for skin preparation before surgery, or a disinfectant and cleanser for skin preparation before injection.   10 povidone iodine solution is a solution mainly used for skin wound disinfection. It does not need to be diluted when used. The disinfectant is applied directly to the damaged skin. It should be applied within 3-5cm around the lesion and applied twice a day. If necessary, the wound can be covered with sterile gauze to avoid infection.   In summary, 10 povidone iodine solution is the most common topical disinfectant. When you need to treat the wound yourself after an injury to the outside of the body, 10 povidone iodine solution is a good choice.

ORLANDO, Fla., July 31, 2024 /PRNewswire/ -- Half the world's population will experience menopause accounting for 47 million women entering the menopause transition annually. A staggering 80% of women in the menopause transition will experience the life altering symptoms of the little known Musculoskeletal Syndrome of Menopause including total body pain and frozen shoulder. Continue Reading A landmark study has officially established the nomenclature for the Musculoskeletal Syndrome of Menopause (MSM), thanks to the pioneering research of Dr. Vonda Wright, an orthopedic sports surgeon, researcher, longevity doctor and Associate Professor of Orthopedic Surgery at the University of Central Florida School of Medicine (UCF SOM). "Clearly, this is an issue that many women experience but is not adequately acknowledged or addressed within the medical establishment," stated Dr Wright. Post this Dr. Wright coined the term "Musculoskeletal Syndrome of Menopause" (MSM) after observing numerous post-menopausal women suffering from orthopedic issues, such as frozen shoulder. Her extensive research has unveiled that a staggering 80% of post-menopausal women endure life-altering musculoskeletal symptoms, with 25% of these women being severely debilitated by them. Despite the prevalence, these symptoms often go unrecognized or misdiagnosed by healthcare providers, leaving many women to suffer in silence. The syndrome encompasses a range of debilitating symptoms, including: Arthralgia (total body pain) Inflammation (e.g., frozen shoulder) Loss of muscle mass Loss of bone density Fat redistribution Rapid increase in arthritis The study highlights the rapid loss of estrogen during perimenopause and menopause as the root cause of MSM. Alarmingly, 40% of women seeking medical care for these symptoms find no structural problems, leading to feelings of being dismissed or misunderstood by clinicians. Dr. Wright's research underscores the urgency of acknowledging MSM in the medical community. Not only is MSM treatable, but it is also preventable through early intervention, lifestyle modifications, and comprehensive knowledge. Without proper treatment, MSM significantly contributes to frailty and increased mortality in women. LINK to the STUDY: Musculoskeletal Syndrome of Menopause The publication of this groundbreaking study coincides with an article in Menopause, which investigates young women with premature menopause experiencing similar symptoms. This further establishes that these musculoskeletal changes are directly linked to hormonal deprivation rather than age. "Clearly, this is an issue that many women experience but is not adequately acknowledged or addressed within the medical establishment," stated Dr Wright. "This research offers a new understanding, hope and nomenclature for clinicians and for women suffering from these symptoms." Dr. Vonda Wright and her team continue to advocate for increased awareness, early prevention, and effective treatment strategies to combat MSM, aiming to improve the quality of life for millions of women worldwide. Dr. Wright is a practicing double boarded Orthopaedic Sports Surgeon, Author, Speaker, Researcher and Innovator serving as a key opinion leader at the intersection of Longevity | Women's Health | Performance. Widely recognized for her thought leadership, Dr. Wright is a frequent media and conference expert. Her innovative science-based approach is changing the lives of millions in mid-life. In addition to treating active people and athletes of all ages and skill levels, she is a clinical champion for ideators in the biotech, sports innovation and longevity environments to develop innovation pipelines. She works to clarify and amplify great ideas through a deep clinical lens while applying entrepreneurial and venture principles to understand, evaluate and stimulate innovation. In addition to her elite orthopaedic practice, her current work includes harnessing the new science of aging to create health optimized longevity plans for high capacity individuals via her "Precision Longevity Experience" and bespoke retreats for women in midlife. An empathetic and dynamic communicator, Dr. Wright's online community spans more than 1.5 million people. Dr. Wright practices in Lake Nona, Florida, and is the founder and CEO of Precision Longevity. For more information, please contact: Dr Vonda Wright MD, MS [email protected] 407-232-2334 @DrVondaWright SOURCE Dr. Vonda Wright

SAN FRANCISCO, Feb. 12, 2024 /PRNewswire/ -- Frozen shoulder, also known as adhesive capsulitis, is a condition characterized by pain and stiffness in the shoulder, resulting in difficulty of movement in the shoulder. It affects 2-5% of the population, typically those between 40 and 60 years of age. People with diabetes and hypothyroidism are at an increased risk. Even without treatment, frozen shoulder can get better with time; however, recovery may take up to three years. Pain medications and physical therapy (PT) are typically used as the main treatments, but there is little evidence supporting the use of PT. Study Comparing Frozen Shoulder Treatments A single-provider, randomized controlled trial (RCT) study presented at the 2024 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) used patient-reported outcome measures (PROMs) and health care costs to compare watchful waiting (WW) versus PT for the treatment and management of frozen shoulder. The study, " Watchful Waiting Achieves Higher Value Than Physical Therapy for the Treatment of Idiopathic Frozen Shoulder: A Prospective Randomized Controlled Trial," randomized 61 patients to either WW (31 patients) or PT (30 patients) and assessed outcomes at six weeks, three months, six months and 12 months. This is the first RCT to compare PT versus WW for frozen shoulder treatment using a value-based health care framework. The primary outcome was the American Shoulder and Elbow Surgeons Score (ASES), and secondary outcomes included the patient value (12-month ASES score divided by health care costs). The outcomes of the study include: WW and PT patients improved significantly at each time point for all PROMs (p<0.05 for all). There were no significant differences between WW and PT treatments at any point in time (p>0.05 for all). PT patients incurred 10 times higher costs than WW patients (normalized mean difference: 1,635.67; 95% CI: 967.19, 2,304.15; p<0.001) and achieved only 16.9% of the patient value (normalized mean difference: -146.97; 95%CI: -207.47, -86.47; p<0.001). Based on the findings of this study, physicians should inform their patients with adhesive capsulitis of the treatment options. These include non-operative management with medications, physical therapy, watchful waiting and surgery when indicated. Physicians may then decide on the most appropriate treatment plan for their patient which may include the patient's preferences and needs. # # # 2024 AAOS Annual Meeting Disclosure Statement About the AAOS With more than 39,000 members, the American Academy of Orthopaedic Surgeons is the world's largest medical association of musculoskeletal specialists. The AAOS is the trusted leader in advancing musculoskeletal health. It provides the highest quality, most comprehensive education to help orthopaedic surgeons and allied health professionals at every career level to best treat patients in their daily practices. The AAOS is the source for information on bone and joint conditions, treatments and related musculoskeletal healthcare issues; and it leads the healthcare discussion on advancing quality. Follow the AAOS on Facebook, X, LinkedIn and Instagram. SOURCE American Academy of Orthopaedic Surgeons